Wegermann, K., Suzuki, A., Sarmiento, E., Li, Y., Wilson, L., Lloyd, A., … Lake, J. (2024). DIFFERENCES IN PREVALENCE OF MASLD WITH CLINICALLY SIGNIFICANT FIBROSIS BY SEX/MENOPAUSE STATUS IN A LARGE PROSPECTIVE US COHORT OF PERSONS WITH HIV. In HEPATOLOGY (Vol. 80, pp. S823–S824).

Wegermann, Kara, Ayako Suzuki, Elisa Sarmiento, Yang Li, Laura Wilson, Audrey Lloyd, Paula Debroy Monzon, et al. “DIFFERENCES IN PREVALENCE OF MASLD WITH CLINICALLY SIGNIFICANT FIBROSIS BY SEX/MENOPAUSE STATUS IN A LARGE PROSPECTIVE US COHORT OF PERSONS WITH HIV.” In HEPATOLOGY, 80:S823–24, 2024.

Wegermann K, Suzuki A, Sarmiento E, Li Y, Wilson L, Lloyd A, et al. DIFFERENCES IN PREVALENCE OF MASLD WITH CLINICALLY SIGNIFICANT FIBROSIS BY SEX/MENOPAUSE STATUS IN A LARGE PROSPECTIVE US COHORT OF PERSONS WITH HIV. In: HEPATOLOGY. 2024. p. S823–4.

Wegermann, Kara, et al. “DIFFERENCES IN PREVALENCE OF MASLD WITH CLINICALLY SIGNIFICANT FIBROSIS BY SEX/MENOPAUSE STATUS IN A LARGE PROSPECTIVE US COHORT OF PERSONS WITH HIV.” HEPATOLOGY, vol. 80, 2024, pp. S823–24.

Wegermann K, Suzuki A, Sarmiento E, Li Y, Wilson L, Lloyd A, Monzon PD, Price J, Woreta T, Crandall H, Sterling R, Loomba R, Chalasani N, Lake J. DIFFERENCES IN PREVALENCE OF MASLD WITH CLINICALLY SIGNIFICANT FIBROSIS BY SEX/MENOPAUSE STATUS IN A LARGE PROSPECTIVE US COHORT OF PERSONS WITH HIV. HEPATOLOGY. 2024. p. S823–S824.